Results for “ ”

Entry Author Date Location
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
Reata Bags $350M as It Preps Rare Chronic Kidney Disease Drug for FDA 06/11/20 Texas
Moderna Finalizes Plan, Dose for Phase 3 Test of mRNA COVID Vaccine 06/11/20 Boston
Verve Therapeutics Adds $63M to Edit Heart Attack Risk Out of Genes 06/11/20 Boston
AbbVie Commits $750M to Genmab Bispecific Antibody Cancer Drug Deal 06/10/20 National
Merck’s Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes 06/10/20 New York
Fauci Foresees “More Than 1 Winner” in Race for COVID-19 Vaccines, Drugs 06/10/20 National
Melinta Expands Antibiotics Lineup With $39M Tetraphase Acquisition 06/09/20 New York
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain” 06/09/20 Boston
Sarepta Eyes Key Test for Gene Therapy in Rare Muscular Dystrophy 06/08/20 Boston
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Legend Biotech’s Upsized IPO Lands $424M for Multiple Myeloma Drug 06/05/20 New York
Bio Roundup: Race and Pharma, ASCO Recap, Warp Speed Ahead & More 06/05/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Cullinan Oncology Reels In $98M to Advance Cancer Drug Pipeline 06/04/20 Boston
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
Early Bird Sale Ends Friday, June 5 for Xconomy’s AI & Drug Discovery Online Forum and Networking Conference 06/04/20 National
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Grail Plants a Seed in RTP, Pledges $100M Investment in New Site 06/02/20 Raleigh Durham
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech 06/02/20 Seattle
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds 05/29/20 National
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs 05/28/20 Seattle
FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies 05/28/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
Page 3 of 1969 « previous page · next page »